Table 1.
Clinical characteristics of head and neck rhabdomyosarcoma patients
| Clinical Characteristics | (%) | Total number | ||
|---|---|---|---|---|
| Gender | 99 (100%) | |||
| Male | 52 | 52.5 | ||
| Female | 47 | 47.5 | ||
| Age (years) | 99 (100%) | |||
| Mean | 16 | |||
| Median | 12 | |||
| Max. | 72 | |||
| Min. | 0.08 | |||
| Age group | 99 (100%) | |||
| Adult | 37 | 37.4 | ||
| Pediatric | 62 | 62.6 | ||
| Tumor site | 99 (100%) | |||
| PM | 64 | 64.6 | ||
| S | 25 | 25.3 | ||
| O | 10 | 10.1 | ||
| Histopathology | 99 (100%) | |||
| ERMS | 33 | 33.3 | ||
| ARMS | 53 | 53.5 | ||
| SRMS-ScRMS | 13 | 13.1 | ||
| Tumor size | 68 (69%) | |||
| Mean | 4.3 | |||
| Median | 4.0 | |||
| Max. | 12 | |||
| Min. | 0.8 | |||
| Regional lymph node | 97 (98%) | |||
| Positive | 40 | 40.8 | ||
| Negative | 57 | 58.2 | ||
| Initial metastasis | 99 (100%) | |||
| Positive | 19 | 19.2 | ||
| Negative | 80 | 80.8 | ||
| Stage | 99 (100%) | |||
| 1 | 29 | 29.3 | ||
| 2 | 10 | 10.1 | ||
| 3 | 41 | 41.4 | ||
| 4 | 19 | 19.2 | ||
| Recurrence | 97 (98%) | |||
| Local | 9 | 9.3 | ||
| Distant | 8 | 8.2 | ||
| Local & distant | 5 | 5.2 | ||
| None | 75 | 77.3 | ||
| Vital status | 97 (98%) | |||
| Alive | 69 | 71.1 | ||
| Deceased | 28 | 28.9 | ||
| Follow-up duration (months) | 97 (98%) | |||
| Mean | 83.6 | |||
| Median | 65 | |||
| Max. | 232 | |||
| Min. | 4 | |||